Methylenetetrahydrofolate Reductase (NADPH2)
This graph shows the total number of publications written about "Methylenetetrahydrofolate Reductase (NADPH2)" by people in the URMC Research Network by year, and whether "Methylenetetrahydrofolate Reductase (NADPH2)" was a major or minor topic of these publication.
Below are the most recent publications written about "Methylenetetrahydrofolate Reductase (NADPH2)" by people in Profiles.
-
Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, Warren SR, Gaziano JM, Lavori P. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study. Am J Kidney Dis. 2009 May; 53(5):779-89.
-
Lim U, Peng K, Shane B, Stover PJ, Litonjua AA, Weiss ST, Gaziano JM, Strawderman RL, Raiszadeh F, Selhub J, Tucker KL, Cassano PA. Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr. 2005 Aug; 135(8):1989-94.
-
Vulapalli R, Liang C, Zareba W, Moss AJ. Recurrent coronary events are not increased in postinfarction patients with methylenetetrahydrofolate reductase gene C677T polymorphism. Am J Cardiol. 2001 Jun 1; 87(11):1289-92.
-
Rothberg PG. Metabolic pathway for leucovorin. Mol Diagn. 2000 Mar; 5(1):5-6.
